COVID-19 Rapid Antigen Test Provides End-to-End Digital Screening Solution
By LabMedica International staff writers Posted on 03 Jun 2021 |
Image: PixoTest POCT COVID-19 Antigen Test (Photo courtesy of iXensor)
A new COVID-19 antigen test provides a full end-to-end digital screening solution to prevent further outbreaks.
iXensor’s (Taipei, Taiwan) PixoTest POCT COVID-19 Antigen Test has received the CE-IVD mark. The iXensor’s PixoTest solution comprises a palm-sized analyzer that reads test results accurately, a digital health pass App, an Admin App, and a HIPAA-grade health management web portal. The fully digitized testing and reporting design shortens the test-to-report time to 15 minutes. In addition to overcoming the lab testing limitations, the solution allows for scaling in large screening settings, thereby enabling business continuity and reopening.
With the PixoTest POCT Analyzer reading test results objectively, healthcare organizations and corporations can minimize the risks of having false-negative cases compared to rapid tests interpreted by human eyes. The analyzer transmits test results simultaneously to the PixoHealth Pass App users via an encrypted QR code. The digital health pass also records App users’ vaccination certificates, helping free movement in the upcoming summer holiday season. The PixoHealth Pass Admin App is designed for organizations to verify the authenticity of PixoTest test results with one simple scan. The admin app protects organizations’ safety amidst the pandemic by validating the cheat-proof, encrypted results shown on PixoHealth Pass App.
“We are deploying iXensor’s core PixoTech technology to develop the smartphone-based self-test that can perform COVID-19 testing and tracking, anywhere at any time,” said Dr. Peter Fitzgerald, Chairman of iXensor and Emeritus Professor of Medicine School at Stanford University. “I believe having COVID-19 at-home test will drastically cut many transmission paths to stop the pandemic.”
Related Links:
iXensor
iXensor’s (Taipei, Taiwan) PixoTest POCT COVID-19 Antigen Test has received the CE-IVD mark. The iXensor’s PixoTest solution comprises a palm-sized analyzer that reads test results accurately, a digital health pass App, an Admin App, and a HIPAA-grade health management web portal. The fully digitized testing and reporting design shortens the test-to-report time to 15 minutes. In addition to overcoming the lab testing limitations, the solution allows for scaling in large screening settings, thereby enabling business continuity and reopening.
With the PixoTest POCT Analyzer reading test results objectively, healthcare organizations and corporations can minimize the risks of having false-negative cases compared to rapid tests interpreted by human eyes. The analyzer transmits test results simultaneously to the PixoHealth Pass App users via an encrypted QR code. The digital health pass also records App users’ vaccination certificates, helping free movement in the upcoming summer holiday season. The PixoHealth Pass Admin App is designed for organizations to verify the authenticity of PixoTest test results with one simple scan. The admin app protects organizations’ safety amidst the pandemic by validating the cheat-proof, encrypted results shown on PixoHealth Pass App.
“We are deploying iXensor’s core PixoTech technology to develop the smartphone-based self-test that can perform COVID-19 testing and tracking, anywhere at any time,” said Dr. Peter Fitzgerald, Chairman of iXensor and Emeritus Professor of Medicine School at Stanford University. “I believe having COVID-19 at-home test will drastically cut many transmission paths to stop the pandemic.”
Related Links:
iXensor
Latest COVID-19 News
- New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
- Long COVID Etiologies Found in Acute Infection Blood Samples
- Novel Device Detects COVID-19 Antibodies in Five Minutes
- CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
- Gut Microbiome Dysbiosis Linked to COVID-19
- Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
- New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
- AI Takes Guesswork Out Of Lateral Flow Testing
- Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
- Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
- Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
- Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
- Blood Test Performed During Initial Infection Predicts Long COVID Risk
- Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
- Finger-Prick Blood Test Identifies Immunity to COVID-19
- Quick Test Kit Determines Immunity Against COVID-19 and Its Variants